Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE

References

• Martínez JL, Baquero F. Emergence and spread of antibiotic resistance: setting a parameter space. Ups J Med Sci. 2014;119:68–77.
   PubMed Web of Science ®Google Scholar
• Payne DJ, Gwynn MN, Holmes DJ, et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 2007;6:29–40.
   PubMed Web of Science ®Google Scholar
• So AD, Gupta N, Brahmachari SK, et al. Towards new business models for R&D for novel antibiotics. Drug Resist Updat. 2011;14:88–94.
   PubMed Web of Science ®Google Scholar
• Ribeiro da Cunha B, Fonseca LP, Calado CRC. Antibiotic discovery: where have we come from, where do we go? Antibiotics (Basel). 2019;8:2.
   Web of Science ®Google Scholar
• Rangel-Vega A, Bernstein LR, Mandujano-Tinoco EA, et al. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. Front Microbiol. 2015;6:282.
   PubMed Web of Science ®Google Scholar
• Monserrat-Martinez A, Gambin Y, Sierecki E. Thinking outside the bug: molecular targets and strategies to overcome antibiotic resistance. Int J Mol Sci. 2019;20:6.
   Web of Science ®Google Scholar
• Rasko DA, Sperandio V. Antivirulence strategies to combat bacteria-mediated disease. Drug Discovery. 2010;9:117–128.
   Google Scholar
• Allen RC, Popat R, Diggle SP, et al. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12:300–308.
   PubMed Web of Science ®Google Scholar
• Rampioni G, Visca P, Leoni L, et al. Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens. Emerg Top Life Sci. 2017;1:13–22.
   PubMedGoogle Scholar
• Moradali MF, Ghods S, Rehm BHA. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7:39.
   PubMed Web of Science ®Google Scholar
• Breidenstein EB, de la Fuente-núñez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19(8):419–426.
   PubMed Web of Science ®Google Scholar
• Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2:1051–1060.
   PubMed Web of Science ®Google Scholar
• Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297–308.
   PubMed Web of Science ®Google Scholar
• Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011;2:65.
   PubMed Web of Science ®Google Scholar
• Alcade-Rico M, Hernando-Amado S, Blanco P, et al. Multidrug efflux pumps at the crossroad between antibiotic resistance and bacterial virulence. Front Microbiol. 2016;7:1483.
   PubMed Web of Science ®Google Scholar
• Jimenez PN, Koch G, Thompson JA, et al. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 2012;76:46–65.
   PubMed Web of Science ®Google Scholar
• Balasubramanian D, Schneper L, Kumari H, et al. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41:1–20.
   PubMed Web of Science ®Google Scholar
• Kirisits MJ, Parsek MR. Does Pseudomonas aeruginosa use intercellular signaling to build biofilm communities? Cell Microbiol. 2006;8:1841–1849.
   PubMed Web of Science ®Google Scholar
• Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med. 2012;2:a012427-a012427.
   PubMed Web of Science ®Google Scholar
• LaSarre B, Federle MJ. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol Mol Biol Rev. 2013;77:73–111.
   PubMed Web of Science ®Google Scholar
• Rampioni G, Leoni L, Williams P. The art of antibacterial warfare: deception through interference with quorum sensing-mediated communication. Bioorg Chem. 2014;55:60–68.
   PubMed Web of Science ®Google Scholar
• Williams P, Cámara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol. 2009;12:182–191.
   PubMed Web of Science ®Google Scholar
• Smith RS, Iglewski BH. P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol. 2003;6:56–60.
   PubMed Web of Science ®Google Scholar
• Hoffman LR, Kulasekara HD, Emerson J, et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros. 2009;8:66–70.
   PubMed Web of Science ®Google Scholar
• Marvig RL, Sommer LM, Molin S, et al. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2015;47:57–64.
   PubMed Web of Science ®Google Scholar
• Feltner JB, Wolter DJ, Pope CE, et al. LasR variant cystic fibrosis isolates reveal an adaptable quorum-sensing hierarchy in Pseudomonas aeruginosa. MBio. 2016;7:5.
   Web of Science ®Google Scholar
• Winstanley C, O’Brien S, Brockhurst MA. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 2016;24:327–337.
   PubMed Web of Science ®Google Scholar
• Guina T, Purvine SO, Yi EC, et al. Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc Natl Acad Sci USA. 2003;100:2771–2776.
   PubMed Web of Science ®Google Scholar
• Jiricny N, Molin S, Foster K, et al. Loss of social behaviours in populations of Pseudomonas aeruginosa infecting lungs of patients with cystic fibrosis. PLoS One. 2014;9:e83124.
   PubMed Web of Science ®Google Scholar
• Barr HL, Halliday N, Cámara M, et al. Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis. Eur Respir J. 2015;46:1046–1054.
   PubMed Web of Science ®Google Scholar
• Heeb S, Fletcher MP, Chhabra SR, et al. Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev. 2011;35:247–274.
   PubMed Web of Science ®Google Scholar
• Dulcey CE, Dekimpe V, Fauvelle DA, et al. The end of an old hypothesis: the Pseudomonas signaling molecules 4-hydroxy-2-alkylquinolines derive from fatty acids, not 3-ketofatty acids. Chem Biol. 2013;20:1481–1491.
   PubMedGoogle Scholar
• Drees SL, Fetzner S. PqsE of Pseudomonas aeruginosa acts as pathway-specific thioesterase in the biosynthesis of alkylquinolone signaling molecules. Chem Biol. 2015;22:611–618.
   PubMedGoogle Scholar
• Rampioni G, Falcone M, Heeb S, et al. Unravelling the genome-wide contributions of specific 2-alkyl-4-quinolones and PqsE to quorum sensing in Pseudomonas aeruginosa. PLoS Pathog. 2016;12:e1006029.
   PubMed Web of Science ®Google Scholar
• Hazan R, He J, Xiao G, et al. Homeostatic interplay between bacterial cell-cell signaling and iron in virulence. PLoS Pathog. 2010;6:e1000810.
   PubMed Web of Science ®Google Scholar
• Rampioni G, Pustelny C, Fletcher MP, et al. Transcriptomic analysis reveals a global alkyl-quinolone-independent regulatory role for PqsE in facilitating the environmental adaptation of Pseudomonas aeruginosa to plant and animal hosts. Environ Microbiol. 2010;12:1659–1673.
   PubMed Web of Science ®Google Scholar
• Farrow JM 3rd, Sund ZM, Ellison ML, et al. PqsE functions independently of PqsR-Pseudomonas quinolone signal and enhances the rhl quorum-sensing system. J Bacteriol. 2008;190:7043–7051.
   PubMed Web of Science ®Google Scholar
• Folch B, Déziel E, Doucet N. Systematic mutational analysis of the putative hydrolase PqsE: toward a deeper molecular understanding of virulence acquisition in Pseudomonas aeruginosa. PLoS ONE. 2013;8:e73727.
   PubMed Web of Science ®Google Scholar
• Zender M, Witzgall F, Drees SL, et al. Dissecting the multiple roles of PqsE in Pseudomonas aeruginosa virulence by discovery of small tool compounds. ACS Chem Biol. 2016;11:1755–1763.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Moustafa DA, Stergioula V, et al. The PqsE and RhlR proteins are an autoinducer synthase-receptor pair that control virulence and biofilm development in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2018;115:E9411–E9418.
   PubMed Web of Science ®Google Scholar
• McCready AR, Paczkowski JE, Cong JP, et al. An autoinducer-independent RhlR quorum-sensing receptor enables analysis of RhlR regulation. PLoS Pathog. 2019;15:e1007820.
   PubMed Web of Science ®Google Scholar
• Klein T, Henn C, de Jong JC, et al. Identification of small-molecule antagonists of the Pseudomonas aeruginosa transcriptional regulator PqsR: biophysically guided hit discovery and optimization. ACS Chem Biol. 2012;7:1496–1501.
   PubMed Web of Science ®Google Scholar
• Ilangovan A, Fletcher M, Rampioni G, et al. Structural basis for native agonist and synthetic inhibitor recognition by the Pseudomonas aeruginosa quorum sensing regulator PqsR (MvfR). PLoS Pathog. 2013;9:e1003508.
   PubMed Web of Science ®Google Scholar
• Zender M, Klein T, Henn C, et al. Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence. J Med Chem. 2013;56:6761–6774.
   PubMed Web of Science ®Google Scholar
• Lu C, Kirsch B, Maurer CK, et al. Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships. Eur J Med Chem. 2014;79:173–183.
   PubMed Web of Science ®Google Scholar
• Starkey M, Lepine F, Maura D, et al. Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog. 2014;10:e1004321.
   PubMed Web of Science ®Google Scholar
• Maura D, Drees SL, Bandyopadhaya A, et al. Polypharmacology approaches against the Pseudomonas aeruginosa MvfR regulon and their application in blocking virulence and antibiotic tolerance. ACS Chem Biol. 2017;12:1435–1443.
   PubMed Web of Science ®Google Scholar
• Maura D, Rahme LG. Pharmacological inhibition of the Pseudomonas aeruginosa MvfR quorum-sensing system interferes with biofilm formation and potentiates antibiotic-mediated biofilm disruption. Antimicrob Agents Chemother. 2017;61. DOI:https://doi.org/10.1128/AAC.01362-17
   Google Scholar
• D’Angelo F, Baldelli V, Halliday N, et al. Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2018;62. DOI:https://doi.org/10.1128/AAC.01296-18.
   Google Scholar
• Soukarieh F, Williams P, Stocks MJ, et al. Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives. J Med Chem. 2018a;61:10385–10402.
   PubMed Web of Science ®Google Scholar
• Soukarieh F, Vico Oton E, Dubern JF, et al. In silico and in vitro-guided identification of inhibitors of alkylquinolone-dependent quorum sensing in Pseudomonas aeruginosa. Molecules. 2018b;23:257.
   PubMed Web of Science ®Google Scholar
• Mellini M, Di Muzio E, D’Angelo F, et al. In silico selection and experimental validation of FDA-approved drugs as anti-quorum sensing agents. Front Microbiol. 2019;10:2355.
   PubMed Web of Science ®Google Scholar
• Grant SG, Jessee J, Bloom FR, et al. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci USA. 1990;87:4645–4649.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 1989.
   Google Scholar
• Massai F, Imperi F, Quattrucci S, et al. A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal. Biosens Bioelectron. 2011;26:3444–3449.
   PubMed Web of Science ®Google Scholar
• Essar DW, Eberly L, Hadero A, et al. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol. 1990;172:884–900.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Gdynia A, Tielen P, et al. The autotransporter esterase EstA of Pseudomonas aeruginosa is required for rhamnolipid production, cell motility, and biofilm formation. J Bacteriol. 2007;189:6695–6703.
   PubMed Web of Science ®Google Scholar
• Rampioni G, Schuster M, Greenberg EP, et al. Contribution of the RsaL global regulator to Pseudomonas aeruginosa virulence and biofilm formation. FEMS Microbiol Lett. 2009;301:210–217.
   PubMed Web of Science ®Google Scholar
• Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280:295–298.
   PubMed Web of Science ®Google Scholar
• Jurcisek JA, Dickson AC, Bruggeman ME, et al. In vitro biofilm formation in an 8-well chamber slide. J Vis Exp. 2011;47:e2481.
   Google Scholar
• CLSI. M07-A9. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 9th ed. Wayne PA: CLSI (Approved standard M07-A9); 2012.
   Google Scholar
• Cramer DL, Dodd MC. The mode of action of nitrofuran compounds; action versus Staphylococcus aureus. J Bacteriol. 1946;51:293–303.
   Web of Science ®Google Scholar
• Lacey RW. A new look at erythromycin. Postgrad Med J. 1977;53:195–200.
   PubMed Web of Science ®Google Scholar
• Schweizer HP. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene. 1991;97:109–121.
   PubMed Web of Science ®Google Scholar
• Higgins S, Heeb S, Rampioni G, et al. Differential regulation of the phenazine biosynthetic operons by quorum sensing in Pseudomonas aeruginosa PAO1-N. Front Cell Infect Microbiol. 2018;8:252.
   PubMed Web of Science ®Google Scholar
• Lau GW, Hassett DJ, Ran H, et al. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med. 2004;10:599–606.
   PubMed Web of Science ®Google Scholar
• Papenfort K, Bassler BL. Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol. 2016;14:576–588.
   PubMed Web of Science ®Google Scholar
• Martínez E, Cosnahan RK, Wu M, et al. Oxylipins mediate cell-to-cell communication in Pseudomonas aeruginosa. Commun Biol. 2019;2:66.
   PubMed Web of Science ®Google Scholar
• Cao H, Krishnan G, Goumnerov B, et al. A quorum sensing-associated virulence gene of Pseudomonas aeruginosa encodes a LysR-like transcription regulator with a unique self-regulatory mechanism. Proc Natl Acad Sci USA. 2001;98:14613–14628.
   PubMed Web of Science ®Google Scholar
• Diggle SP, Winzer K, Chhabra SR, et al. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. Mol Microbiol. 2003;50:29–43.
   PubMed Web of Science ®Google Scholar
• De´ziel E, Gopalan S, Tampakaki AP, et al. The contribution of MvfR to Pseudomonas aeruginosa pathogenesis and quorum sensing circuitry regulation: multiple quorum sensing-regulated genes are modulated without affecting lasRI, rhlRI or the production of N-acyl-L-homoserine lactones. Mol Microbiol. 2005;55:998–1014.
   PubMed Web of Science ®Google Scholar
• Xiao G, Déziel E, He J, et al. MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR-class regulatory protein, has dual ligands. Mol Microbiol. 2006;62:1689–1699.
   PubMed Web of Science ®Google Scholar
• Lesic B, Lépine F, Déziel E, et al. Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog. 2007;3:1229–1239.
   PubMed Web of Science ®Google Scholar
• Dubern JF, Cigana C, De Simone M, et al. Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific. Environ Microbiol. 2015;17:4379–4393.
   PubMed Web of Science ®Google Scholar
• Lau GW, Goumnerov BC, Walendziewicz CL, et al. The Drosophila melanogaster toll pathway participates in resistance to infection by the Gram-negative human pathogen Pseudomonas aeruginosa. Infect Immun. 2003;71:4059–4066.
   PubMed Web of Science ®Google Scholar
• Maura D, Hazan R, Kitao T, et al. Evidence for direct control of virulence and defense gene circuits by the Pseudomonas aeruginosa quorum sensing regulator, MvfR. Sci Rep. 2016;6:34083.
   PubMed Web of Science ®Google Scholar
• Huang H, Shao X, Xie Y, et al. An integrated genomic regulatory network of virulence-related transcriptional factors in Pseudomonas aeruginosa. Nat Commun. 2019;10:2931.
   PubMed Web of Science ®Google Scholar
• Mashburn LM, Whiteley M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature. 2005;437:422–425.
   PubMed Web of Science ®Google Scholar
• Bredenbruch F, Geffers R, Nimtz M, et al. The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol. 2006;8:1318–1329.
   PubMed Web of Science ®Google Scholar
• Diggle SP, Matthijs S, Wright VJ, et al. The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol. 2007;14:87–96.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang W, Cheng J, et al. A Pseudomonas T6SS effector recruits PQS-containing outer membrane vesicles for iron acquisition. Nat Commun. 2017;8:14888.
   PubMed Web of Science ®Google Scholar
• Yu S, Jensen V, Seeliger J, et al. Structure elucidation and preliminary assessment of hydrolase activity of PqsE, the Pseudomonas quinolone signal (PQS) response protein. Biochemistry. 2009;48:10298–10307.
   PubMed Web of Science ®Google Scholar
• Sharma S, Anand N. Approaches to design and synthesis of antiparasitic drugs. Pharmacochemistry Lib. 1997;25:421–438.
   Google Scholar
• Vass M, Hruska K, Franek M. Nitrofuran antibiotics: a review on the application, prohibition and residual analysis. Vet Med. 2008;53:469–500.
   Web of Science ®Google Scholar
• Olive PL, McCalla DR. Cytotoxicity and DNA damage to mammalian cells by nitrofurans. Chem Biol Interact. 1977;16:223–233.
   PubMed Web of Science ®Google Scholar
• McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994;33:23–30.
   PubMed Web of Science ®Google Scholar
• Yang L, Rybtke MT, Jakobsen TH, et al. Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrob Agents Chemother. 2009;53:2432–2443.
   PubMed Web of Science ®Google Scholar
• Imperi F, Leoni L, Visca P. Antivirulence activity of azithromycin in Pseudomonas aeruginosa. Front Microbiol. 2014;5. DOI:https://doi.org/10.3389/fmicb.2014.00178
   Google Scholar
• Gödeke J, Pustelny C, Häussler S. Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:1617–1624.
   PubMedGoogle Scholar
• Balaban NQ, Helaine S, Lewis K, et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019;17:441–448.
   PubMed Web of Science ®Google Scholar
• Imperi F, Massai F, Facchini M, et al. Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proc Natl Acad Sci USA. 2013;110:7458–7463.
   PubMed Web of Science ®Google Scholar
• Imperi F, Massai F, Ramachandran Pillai C, et al. New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrob Agents Chemother. 2013;57:996–1005.
   PubMed Web of Science ®Google Scholar
• Davies J, Spiegelman GB, Yim G. The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol. 2006;9:445–453.
   PubMed Web of Science ®Google Scholar
• Yim G, Wang HH, Davies J. Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci. 2007;362:1195–1200.
   PubMed Web of Science ®Google Scholar
• Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623–628.
   PubMed Web of Science ®Google Scholar
• Wermuth CG. Selective optimization of side activities: the SOSA approach. Drug Discov Today. 2006;11:160–164.
   PubMed Web of Science ®Google Scholar
• Elsaman T, Mohamed MS, Mohamed MA. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents. Bioorg Chem. 2019;88:102969.
   PubMed Web of Science ®Google Scholar